Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Here is a link for those interested in the technical aspects of PEMF: http://www.alenov.com/fileupload/PEMFcorrected_new.pdf
For the non technical here is the paper Summary:
As Evidenced by the many studies cited herein, it is clear that PEMF treatment stimulates many aspects of cellular activity and, in doing so, promotes neural regeneration and brain function, improves neuro-muscular function and general health.
Beyond the complex mechanisms by which it operates remain the health benefits associated with PEMF therapy. PEMF therapy increases blood circulation in and around damaged tissue, and effectively helps damaged cells heal. Generally PEMF therapy produces one main effect; it stimulates the cell metabolism by increasing the flow of electrons and ions across the cell membrane. This effect involves a chain of processes in the human body, which leads to the improvement of health without side effects.
100% correct yankee. With 275 more Boots stores stocking ActiPatch on their shelves as of April the second quarter should be impressive.
Thanks seven. This is my issue with market shorting. Analyst say it is a stabilizing factor to help prevent exuberance in the market. I say BS, the shorts dream scenario is to drive a company into BK so that they never have to cover the short sale or pay taxes on the profits.
Canadian 7 Day Trial Program bringing in new customers!
Ben F on May 27, 2015
I had really bad shoulder pain from reconstructive surgery and I was sick of taking pain pills all the time which never really worked anyways. I was skeptical about using ActiPatch at first but I sent off for this 7 day trial and it really did reduce my shoulder pain. This device not only reduced the pain but gave me my mobility back!
Alex R. on May 24, 2015
I love my ActiPatch. They're incredible. I use mine for headaches, menstrual pain/cramps, & arthritis. I know my friend used it for a toothache, pain in the chest from coughing and another used it for costochondritis. I'm not sure if there's anything these loops can't help with! :)
http://www.actipatch.ca/products/actipatch-pain-relief-7-day-trial-canada
Gota Luv the Penny Market!! A fresh face showed up preaching doom and gloom, calling BIEL a POS. If you research fresh face you find that fresh face is promoting LVGI, a pillar of the equities market with 4 reverse splits under it's belt that is trying to market prepackaged alcoholic shot drinks and hemp products.
That will be the challenge for some investors here art, resisting the urge to take a quick 50% gain and hold out for the big score that is coming.
Welcome to BIEL Janus. I hope that you stick around as there is much more Action in the pipeline.
It has been a long waiting game seven but today feels Marvelous simply Marvelous!! Up 76% on 52 Mil in volume!!
BIEL up 52% on 45 Mil in volume in 1 hour & 12 minutes of trading!!
Over 7 million shares snapped up at the bargain price of .001 !!
To not recognize that BIEL has momentum and come along for the ride exceeds stupidity.
Today is an early warning of what is coming for BIEL. Those who are paying attention will be rewarded.
Better move the rhetoric into hyperdrive.
Up 28% on 54 million shares traded. Looks like somebody got a tip that FDA will announce.
So sorry to hear of your loss lizanne.
Tens units have one function, to block the pain signal that your body is trying to send to your brain. The ActiPatch with PEMF technology helps your body heal by increasing blood flow to damaged cells and reducing inflammation. The result of your body's cells healing is reduced pain.
Pain is your body's way of telling you that there is a problem.
Do people want a product that tricks their brain or one that helps to heal the problem.
So where is the .0003 & .0002 that you were predicting 2 weeks ago?
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=113324525
"Sounds like this might be the BielBeginning of .0003
Excellent! Maybe Biel will go to .0002 now so we can grab some more BielBull."
When the Bears increase their negative rhetoric a break out to the up side is usually close at hand.
AW Interview, @ 9:50 in part one AW gives optimism for an FDA Reclassification decision this month.
"And we will get through the FDA here, hopefully, God willing this month we'll get some clearance as to what the classification will be."
AW making the case for less regulations on a low power device:
" We've gone back to them (FDA) and said, hey guys, we have two things, one we want to obviously support the reclassification from class 3 to class 2 but more importantly we want to look at our device because its slightly different. I mean we are operating at 73 micro watts at issue level. Our power level is 1/200th of a cell phone in terms of risk. But its that pulsing, and that's part of what we are testing on our new devices, what is the optimum pulse rate that the device should work at."
AW said that a large part of the FDA delays with approvals are due to them not understanding the mechanism of action. They associate SWD devices with heating tissue but the pulsing of PEMF therapy does not operate by heating. Working with the NY State University the mechanism of action for the Actipatch has been defined as the disruption of the Efferent Nerves which creates a muscle response which increases blood flow, reducing inflammation and pain, and accelerates the body's healing process.
AW states that 20-30% of humans experience chronic pain, 1.5 Billion people world wide. In the US its 116 Million people.
$40 Billion is spent annually on drug therapy but 80% of the patients still report high levels of discomfort, 8.2 on a 10 point scale. 80-85% of this pain is Musculoskeletal which is what the Actipatch is designed for at a cost of 4 cents per hour.
AW interview, it does not get any better than this folks! The host, Michael Yorba's opening remarks:
" I personally have seen these devices work. They actually work effectively, so effectively that people don't need drugs any more when it comes to pain relief."
" I know somebody that had severe back, chronic back pain. They were using codeine bordering on morphine. They got your product and they don't have to use drugs any more to relieve the pain."
Unless stockdarock can provide proof of his "Fake Bid Theory" he should identify it as his opinion of why the Bid volume has gone through the roof. Now at over 60 million shares.
Unless you can provide proof of this theory please identify it as your opinion of why the Bid volume has gone through the roof. Now at over 60 million shares.
It is interesting how all the events that appear positive for BIEL are discounted as a mirage by two posters on this board.
Thanks lizanne. It is a crime that the ActiPatch, an effective, safe, non-drug, non-addictive pain reliever is not available to all Americans.
Post 48821 supports the fact that PEMF is a proven technology. As does this article from the Journal of the American Society of Plastic Surgeons:
Plastic & Reconstructive Surgery:
April 2015 - Volume 135 - Issue 4 - p 1185
Abstract 16: PEMF Accelerates Reduction of Post-Operative Pain and Inflammation: Application to Plastic and Reconstructive Surgical Procedures
Conclusion: This study demonstrates that PEMF rapidly reduces postoperative pain and inflammation for both simple and complex surgical procedures, resulting in decreased narcotic use and morbidity. PEMF therapy has no known adverse effects and provides a simple, non pharmacological adjunct for the management of postoperative pain and inflammation, thus enhancing surgical recovery.
http://journals.lww.com/plasreconsurg/Citation/2015/04000/Abstract_16___PEMF_Accelerates_Reduction_of.81.aspx
Regarding the power issue, here is a repost of a repost since some on this board have short memories:
We went through the "low power" thing last month. Does the State University of New York ring a bell? Some posts on this board are sounding like a piece of vinyl that will not properly reproduce sound. Therefor I will continue that theme with a repost of my 2/23 post answering the same question.
"By placing the ActiPatch directly onto the injured tissue the microchip can deliver an equivalent dosage of a full size pulsed diathermy device.
The Bioelectromagnetics Research Laboratory, State University of New York has established that ActiPatch Therapy is providing an equivalent and adequate dosage of electromagnetic energy for the treatment of soft tissue. ”ActiPatch Therapy emits a pulsed 1000 Hz signal that is propelled into the body on a 27 MHz frequency wave. These waves introduce an electromagnetic field into the affected tissue and creates a low frequency electrical current in the damaged tissue. Each pulse is 100 µsec in duration at a duty cycle of 10% (turned off for 900 µsec,). The induced electrical current affects the cells which have been traumatized and physically separated by intercellular fluids, precluding the individual cells in the tissue from communicating with one another. Electrotherapy?s induced electrical signal serves as a synchronization signal, allowing cells to reestablish communication and begin working as a tissue again and terminating the inflammatory response. Exposures in the extremely low frequency range (less than 3000 Hz) induced electric field levels of less than 10 microvolts/centimeter, corresponding to induced power levels less than 10-12 W/cm3, are sufficient to produce significant biological effects.
While much smaller energy levels are required to achieve a biological stimulation, the field intensities utilized by ActiPatch devices are still well above the threshold levels established by the NIH Working Group. Based on recent work focusing on establishing thresholds for continuous cell exposure, ActiPatch devices induce electric fields which are at least 10 times the threshold levels required to achieve a biological response.
Key points of evaluation:
? Cumulative absorbed energy at the skin level is equivalent to traditional high power devices.
? Effect of continuous delivery provides greater therapeutic benefit.
? The BioElectronics therapy power level is 6 to 9 orders of magnitude higher than that which is required to show a biological effect.
Two key questions arise:
? Is the reduced power of the ActiPatch compensated by the close proximity to the tissue and the longer treatment durations, and
? Is the device delivering an efficacious therapeutic dose of electromagnetic energy to the tissues?
The answer to both of these questions is “Yes”. While the ActiPatch field intensity is 150 times less than the traditional devices, ActiPatch is used continuously, as compared to the relatively short treatments. An antibiotic analogy would possibly be that of a time released patch: a timed release distributes therapy throughout the day instead of in one or two doses. Total dose to the tissues is similar. In the same manner, therapeutic, efficacious PEMFs are induced in the tissues by the ActiPatch, resulting in increased capillary flow, edema reduction, and the other effects discussed.
The literature on PEMF effects shows that the ActiPatch power level is 6-9 orders of magnitude above the threshold for demonstrated cell and tissue effects in vitro. Required power density levels to achieve field-induced tissue effects are shown in the table below. PEMFs have been shown to influence cell behavior in in-vitro models wound healing, of morphological adaptation (cellular alignment in the induced electric field), and in vitro models of differentiation.
The ActiPatch affixes onto patient for a convenient 24-hour treatment, with an “overnight” suggested minimum treatment time. Therapeutic efficacy requires consideration of the treatment time difference factor. ActiPatch Therapy Device produces a 24 hour absorbed energy of 630 mJ/cc compared to traditional pulsed electromagnetic devices which produce a 15 minute absorbed energy in the range of 110 mJ/cc at the 1.5 watt power setting This suggests that a 6 to 8 hour ActiPatch Therapy treatment is well within the range of efficacy for soft tissue injuries.
http://bielcorp.com/wp-content/uploads/2010/07/Physics-and-Clinical-Evidence-of-BioElectronics-V3.pdf
American Academy of Orthopaedic Surgeons 04/13/2015
Study Examines Use of PEMF to Treat Knee Conditions
Pulsed electromagnetic field therapy found effective, well-tolerated
Jennie McKee
Findings of a randomized, controlled trial performed in Italy suggest that biophysical therapy with pulsed electromagnetic fields (PEMF) can be used to successfully treat patients with symptomatic bone marrow edema (BME) or localized cartilage injury.
PEMF—which permeates joints and articular cartilage—is “an easy-to-use treatment that avoids any possible side effects typical in drug treatments,” according to the authors of Scientific Poster 113, on display in Academy Hall G. The authors add that PEMF therapy is “well-tolerated by patients.”
According to the investigators, PEMF has been found effective in treating patients in the first stages of spontaneous osteonecrosis of the knee. This study, however, analyzed whether PEMF is effective in patients with BME of the knee.
http://www.aaos.org/news/acadnews/2015/aaos8_3_26.asp
100% correct yankee!! Boots is in business to make money by satisfying the needs of consumers. The 308 Boots stores that were stocking the ActiPatch were meeting or exceeding Boots sales projections. Boots did what any company would do when they noticed a product that was in demand, they expanded the availability by stocking it in 275 more stores.
When you see posts claiming that no one is buying the ActiPatch know that they are 100% false (deliberately made or meant to deceive).
Congrats on becoming the board's newest moderator yankee! Thank you for making the commitment.
I Positively second that motion.
There are many tricks used by brokers to obscure what is actually happening. If someone says they want to buy 500,000,000 shares at "x" price the broker will do what ever it takes to earn that commission.
When John Malone wanted another 10% of Sirius to give him control everyone was looking for a big price jump. He made the purchases with Forward Contracts telling the brokers what he would pay for hundreds of millions of shares and they delivered. He did not take delivery of the shares until the contract was complete and thus did not have to disclose his buying as it was going on.
The buy back is working well for Sirius XM. Over 1 Billion shares repurchased to date. Sirius traded for as low as 5 cents due to the FCC delaying a merger with XM (hummm, federal agency delays, sounds familiar) and the great recession credit squeeze. Sirius now produces more revenue than any other radio company in the United States and uses some of those profits to buy back stock.
3.87 Up 0.02(0.52%) 10:42AM EDT - Nasdaq Real Time Price
Thanks seven. A 275 store increase, nearly twice as many stores now selling the ActiPatch!! Gotta Love That!!
Thanks for the research ddls. To find a customer complaint on the ActiPatch you had to go back 4 years. Any company on the planet would kill to have that customer satisfaction ratio.
I think that BIEL could set up a good percentage of the BPH sales on a subscription basis as uksausage just brought up the Allay subscription. Sold over the internet with low overhead, mailing them out every 60 days and billing a CC, margins would be much higher.
When Fred sees that Bob is taking fewer bathroom breaks he is going to want to know why. The word will spread fast.
100% correct seven. BPH care and treatment is estimated to cost 26 Billion in the US. That is one heck of a market! What man would not want to give PEMF a try at easing his BPH symptoms before going under the knife.
http://www.nature.com/pcan/journal/v10/n1s/full/4500950a.html
Thanks for posting the complete study seven. An average 57% prostate size reduction in three weeks of therapy is Amazing!! And this impressive result was achieved with a noninvasive 5 minute treatment administered twice a day that produced no negative side effects. It would be another major dropping of the ball by the medical community if a follow up human trial is not done.
Noninvasive and no side effects are the two major PEMF positives.
I saw an article recently about a new prostate procedure called prostatic artery embolization or PAE. The theory being that if a catheter is inserted in the leg artery that feeds blood to the prostate a balloon like device can then be inserted to temporarily stop blood flow to the prostate, providing a shock to the enlarged prostate. What could go wrong there??? The article promoted the procedure as less dangerous than full blown surgery.
14.8 million shares purchased at the .0007 ask today while only 176k has been sold at the .0006 bid. That is over 98% of todays action transacting at the .0007 ask.
NoPink, Per the Press Release on the UK Distributorship:
"RecoveryRx® is a micro medical device that treats acute and chronic musculoskeletal pain and decreases oedema. RecoveryRx® will be introduced in the B. Braun enhanced recovery surgical programs, particularly hip and knee joint replacement and spine surgery, as well as use in orthopaedic trauma. RecoveryRx® in joint replacements will enable better “prehabilitation” in preparation for surgery and provide improved acute post-operative pain relief, earlier mobilization, faster less painful rehabilitation and better restoration of function."
The doctors don't have to have personal knowledge of the RecoveryRX. RecoveryRX is a component of the Braun Enhanced Recovery Surgical Programs. The doctors know the Braun reputation, they order an Enhanced Recovery Program, a RecoveryRX sale has been made.
"How big is that...." Enormous seven!!!
The large price tag of the clinical trials that the FDA requires for their blessing has been BIEL's major hurdle. Now we have a multi billion dollar company doing trials at no cost to BIEL.
100% correct fuja. As Dr Kotak said, BIEL will be successful with or without the FDA. I have been doing some research on the FDA and AMA. It is astounding how much politics/greed has controlled their actions/inaction. I will share some facts when I have done some more research.
Thanks for sharing your experience seven. I have also had similar benefits. It makes a lot of sense. One of the key factors in prostate disease is a reduced blood flow as men age. Nutrients are slowed getting in and toxins are slowed getting out. ActiPatch increases blood flow allowing the prostate to breathe.
This will be a major area for BIEL in the future. Noninvasive is the future of medicine. No hospital stays, no risk to the patient. Insurance companies need to get behind PEMF as it will save them billions in patient care costs.
32 Million Dollar Man uses PEMF to heal foot. The MLB White Sox pitcher Chris Sale is using PEMF therapy to heal his injured foot.
http://www.southsidesox.com/2015/3/27/8298641/white-sox-injury-updates-chris-sale-therapy-a-course-for-a-horse